Resumption of Routine Cancer Screening during the COVID-19 Pandemic : Guidelines

CADTH conducted a Rapid Response Report to search for evidence-based guidelines regarding resuming routine cancer screening during the COVID-19 pandemic. One evidence-based guideline from the American Gastroenterological Association (AGA) Institute was identified. However, no evidence-based guidelines that were either broader in scope, or specific to other fields, were identified. Link to Report Resumption of Routine […]

What You Should Know About Dexamethasone for Treating COVID-19

This tool provides general information about the drug dexamethasone, its past uses, and new evidence for dexamethasone as a potential treatment for COVID-19. The results from the dexamethasone arm of the RECOVERY trial are provided, together with the current Canadian recommendations for its use in treating COVID-19. Link to Tool What You Should Know About […]

Lopinavir-Ritonavir for the Treatment and Prevention of COVID-19: A Review of Clinical Effectiveness

HIV medications lopinavir and ritonavir (LPVR), in combination, are currently being investigated as a proposed COVID-19 treatment. The potential mechanism of action of LPVR is that it may disrupt the replication and spread of the severe acute respiratory syndrome coronavirus 2 — or SARS-CoV-2 — within the body. However, there is uncertainty around the clinical […]

Technologies to Address the Negative Effects of Social Isolation for Older Adults Living in Long-Term Care

CADTH conducted a limited literature search to identify a list of potential technologies that may be used to address the negative effects of social isolation on older adults living in long-term care. A list of technologies that encourage engagement and communication is identified; these include technologies for robotic companions and pets, physical activities and games, […]

CADTH Emerging Health Technology for COVID-19: Favipiravir

Favipiravir is an oral antiviral drug that has emerged as a potential treatment or prevention option for COVID-19. An international expert panel issued a weak recommendation for not using favipiravir in patients with non-severe or severe COVID-19 because of low-quality evidence. Favipiravir is not approved in Canada and is not currently accessible outside of clinical […]

Ongoing Trials for Novel Vaccines in the Prevention of COVID-19

This report provides information on ongoing clinical trials of novel vaccines being investigated for the prevention of COVID-19. It is current as of August 10, 2020, and no further updates will be posted. A list of online tracking tools for up-to-date information on ongoing vaccine trials for COVID-19 is provided in Appendix 1 of this […]